IL27RA and neoplasm: In addition, significantly increased Treg cell percentages were observed in TDLN (day 28; Fig. 4C) and in the spleen (Fig. 4D) of Il27ra−/− mice with PyMT tumor transplants, compared to Il27ra+/+ controls.